Authors
Latest:
Best Communication Practices to Explain Palliative Care PlansKatie Schlenker, DO, emphasizes the importance of empathy during tough conversations with skin cancer patients with few to no treatment options left.
Latest:
Clascoterone cream 1% targets androgen receptorsThe topical cream is the first acne drug with a new mechanism of action to win FDA approval in the last 40 years.
Latest:
Tracee Blackburn, PA-C: Gut Health for Healthy SkinBlackburn presented integrative medicine pearls on gut and hormone health at the 2024 Diversity in Dermatology meeting.
Latest:
From Clinic to Industry: Insights Into the MSL Role and PA AdvocacyAt the 2024 SDPA Fall Conference, Sara Wilchowski, DMSc, MPAS, PA-C, highlighted the challenges and rewards of transitioning to industry roles, the impact of “Insta-Tok” on patient care, and the evolving landscape of dermatology.
Latest:
Rocco Serrao, MD Looks Ahead to Bimekizumab’s ApprovalWe had the chance to catch up with Serrao before he took the stage and he explained why dermatology clinicians should keep their eyes on bimekizumab’s data and shared opportunities for further research.
Latest:
LEAP-010 Study Discontinued for Patients with PD-L1-Expressing HNSCCA coprimary end point in the phase 3 LEAP-010 study will not be met.
Latest:
Retinoic Acid, Vitamin A Demonstrates Role in Regulating Hair Follicles and Epidermal Stem CellsIn vitro studies demonstrated that retinoic acid aids stem cells in transitioning away from a state of flexibility in wound healing.
Latest:
Looking Ahead to the 2023 ACMS MeetingThe ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.
Latest:
CAGE Bio Advances Skin Disease TreatmentMitragotri's work bridges advanced drug development and skin care for tailored treatments.
Latest:
Advancing Recognition and Treatment of Allergic Contact DermatitisJiaDe Yu, MD, discussed important clinical issues in allergic contact dermatitis at the AAD Annual Meeting.
Latest:
IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic ArthritisPanelists discuss how inhibition of IL-17 in psoriasis treatment significantly improves quality of life by reducing inflammation, skin lesions, itching, and pain. Patients report better psychological well-being, increased social confidence, and improved daily functioning as inflammatory pathways are interrupted.
Latest:
Steven Dayan, MD, FACS: Prioritizing Patient Satisfaction in Cosmetic DermatologySteven Dayan, MD, FACS, first author behind a recent study involving high rates of patient satisfaction following treatment with botulinum toxin, discusses the importance of placing patient satisfaction at the forefront of cosmetic dermatology.
Latest:
Elevate-Derm West Conference 2024 RecapReview insights from a premier dermatology event with expert sessions, hands-on insights, and networking to elevate clinical practice.
Latest:
Looking at the scalp and nails during a skin exam is keyA presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.
Latest:
Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne VulgarisIn the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.
Latest:
Unmasking Botulinum Toxin MythsMisleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.
Latest:
Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With MelanomaAn expert discusses initial thoughts on the case, including the risk category the patient would fall into based on the characteristics of their lesion, outlines the treatment guidelines for melanoma based on their risk, and suggests the frequency of surveillance visits solely based on their traditional risk classification.
Latest:
Getting JAK’d With Amy Spizuoco, DO, FAOCDThe JAK inhibitors have demonstrated efficacy, yet some clinicians are still wary of prescribing them. Amy Spizuoco, DO, FAOCD, shares tips to help clinicians improve their comfort in using them.
Latest:
Drug Price Hikes Already Found in 2023List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.
Latest:
Marcella R. Aquino, MD, FACAAI: Don’t Make a Rash DxMarcella R. Aquino details issues in differential diagnosis for rashes that mimic allergic skin conditions at the ACAAI Annual Meeting.
